Taken together, these results demonstrate that the acetylation of COP1 by KAT6A stabilizes β-catenin by impairing β-catenin ubiquitination, resulting in the abnormal activation of the β-catenin signaling pathway and promoting the proliferation and metastasis of ovarian cancer cells. This evidence concerns the gene KAT6A and ovarian cancer.